Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,568.83
+166.21
(+0.33%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Arbutus Biopharma Corporation (I9DN.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.4540
-0.1220
(-4.74%)
At close: 08:06AM CEST
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in USD.
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
18,141
18,141
39,019
10,988
6,914
Cost of revenue
-
-
-
-
47,481
Gross profit
-
-
-
-
-40,567
Operating expenses
Research development
73,700
73,700
84,408
65,502
49,338
Selling general and administrative
22,475
22,475
17,834
17,136
14,845
Total operating expenses
96,175
96,175
102,242
82,638
64,183
Operating income or loss
-78,034
-78,034
-63,223
-71,650
-57,269
Interest expense
459
459
1,726
2,857
4,011
Total other income/expenses net
-44
-44
-2,255
-1,867
-3,206
Income before tax
-72,849
-72,849
-65,012
-76,247
-63,745
Income tax expense
0
0
4,444
0
0
Income from continuing operations
-72,849
-72,849
-69,456
-76,247
-63,745
Net income
-72,849
-72,849
-69,456
-76,247
-63,745
Net income available to common shareholders
-72,849
-72,849
-69,456
-88,386
-75,868
Basic EPS
-0.46
-0.44
-0.46
-0.83
-1.00
Diluted EPS
-0.46
-0.44
-0.46
-0.83
-1.00
Basic average shares
162,714
165,960
150,939
106,242
75,835
Diluted average shares
162,714
165,960
150,939
106,242
75,835
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.